Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Research indicates Dihexa treatment can improve functional outcomes in animal models of cognitive impairment, with behavioral improvements correlating with structural brain changes including increased synaptic density and improved neural connectivity patterns
Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500
It doesn't just fix one thing
Transepithelial transport of glutathione in vascularly perfused small intestine of rat
It is the recommended diluent for reconstitution of lyophilized peptide research compounds including GLP-3, MOTS-C, BPC-157, TB-500, Tesamorelin, and all blended formulations
doi: 10.1016/s1470-2045(13)70104-9 21 WhiteSSBirnbaumLS
US$ 21.29
US$ 25.37
US$ 22.55
US$ 22.29
US$ 26.43
US$ 27.12
US$ 23.32